Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Autor:
Yeon Joo Kim, Ha Kyun Chang, Sang Hee Youn, Myong Cheol Lim, Sang Yoon Park, Sang Soo Seo, Sokbom Kang, Joo-Young Kim
Publikováno v:
International Journal of Gynecologic Cancer. 30:764-771
ObjectiveThe aim of this study was to compare the clinical outcomes of chemoradiotherapy with or without bevacizumab in patients with newly diagnosed International Federation of Gynecology and Obstetrics (FIGO) stage IVB cervical cancer.Methods41 pat
Publikováno v:
International Journal of Gynecologic Cancer. 29:42-47
IntroductionStandard treatment for locally advanced cervical cancer (LACC) includes concomitant chemoradiotherapy (CRT) that typically controls localized disease. However, most patients develop distant metastasis, ultimately leading to death.Objectiv
Autor:
Mojgan Devouassoux-Shisheboran, Akila N. Viswanathan, Keiichi Fujiwara, Jonathan A. Ledermann, Isabelle Treilleux, Nicholas S imon Reed, Diane Provencher, Patricia Pautier, Yuji Takei, Sven Mahner, Elizabeth Åvall-Lundqvist, Linda Mileshkin, Toyomi Satoh
Publikováno v:
International Journal of Gynecologic Cancer. 24:S102-S108
Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical cancer. Compared with other common histological types, squamous cell carcinoma or adenocarcinoma, the outcome of SCCC is poor because of the high incidence of
Autor:
Richard R. Barakat, Yukio Sonoda, Fady Khoury-Collado, Vaagn Andikyan, Roisin E. O'Cearbhaill, Dennis S. Chi, Samith Sandadi, Jason A. Konner, Nadeem R. Abu-Rustum, William P. Tew
Publikováno v:
International Journal of Gynecologic Cancer. 23:923-928
ObjectiveIt is well documented that recurrence after pelvic exenteration remains high (up to 50%), and patients may require a prolonged period of recuperation following this aggressive surgery. We conducted a retrospective review to evaluate the feas
Autor:
Rebecca McCaffrey, Joseph T. Chambers, Ernest I. Kohorn, Setsuko K. Chambers, Peter E. Schwartz, Mert Ozan Bahtiyar
Publikováno v:
International Journal of Gynecologic Cancer. 21:535-544
ObjectiveThe mature results of the neoadjuvant and adjuvant chemotherapy arms of the nonrandomized, phase 2 Yale University cisplatin, bleomycin, methotrexate, and 5-FU protocol are presented.MethodsSixty-seven patients were prospectively accrued wit
Publikováno v:
International Journal of Gynecologic Cancer. 19:460-465
Carboplatin is one of the most commonly used and well-tolerated agents for gynecologic malignancies. The rate of hypersensitivity reactions (HSRs) in the overall population of patients receiving carboplatin has been reported to increase after multipl
Autor:
Hadi Shojaei, Zahra Eftekhar, Zahra Rezaei, Þ Fariba Yarandi, Narges Izadi-Mood, Saeedeh Mohagheghi
Publikováno v:
International Journal of Gynecologic Cancer. 19:249-252
Background:There are therapeutic dilemmas regarding fertility-preserving treatment among young women with well-differentiated endometrial carcinoma.Materials and Methods:Twenty-one patients with stage IA well-differentiated endometrial adenocarcinoma
Publikováno v:
International Journal of Gynecologic Cancer. 18:1367-1371
We report five patients with early-stage cervical cancer who do not fulfill criteria of fertility-sparing surgery (tumor more than 2 cm in the biggest diameter or infiltrating more than half of stroma). Five patients received three cycles of dose den
Autor:
Seiryu Kamoi, Keisuke Kurose, Osamu Mori, Yoshiharu Ohaki, Toshiyuki Takeshita, Masaharu Fukunaga
Publikováno v:
International Journal of Gynecologic Cancer. 18:1305-1314
This study aimed to document chronologic histologic changes of endometrial biopsies from patients with endometrial adenocarcinoma on high-dose progestin therapy. Seven patients with presumptive FIGO stage IA endometrial adenocarcinoma treated with me
Autor:
Junzo Kigawa, Tetsuro Oishi, Ruri Shimogai, Yasunobu Kanamori, Muneaki Shimada, Wakae Kawaguchi, Naoki Terakawa, Shinya Sato, Masakuni Takahashi, Hiroaki Itamochi
Publikováno v:
International Journal of Gynecologic Cancer. 17:1040-1046
Our previous findings suggested that lower cell proliferation of clear cell carcinoma (CCC) of the ovary may contribute to its resistance to chemotherapy. We conducted the present study to find the gene that regulates cell proliferation of CCC and to